SY

So-Young International Inc
NASDAQHEALTHCAREHEALTH INFORMATION SERVICES

Key Statistics

Market Cap
$156.59M
P/E Ratio
EPS
$-0.36
Beta
2.02
52W High
$6.28
52W Low
$1.28
50-Day MA
$2.22
200-Day MA
$2.90
Dividend Yield
Profit Margin
-15.60%
Forward P/E
16.29
PEG Ratio

About So-Young International Inc

So-Young International Inc. operates an online platform for consumer health and medical aesthetic services that focuses on discretionary medical treatments.

Official WebsiteChinaFY End: December

Fundamentals

Revenue (TTM)$1.66B
Gross Profit (TTM)$763.61M
EBITDA$-220.91M
Operating Margin-13.40%
Return on Equity-15.00%
Return on Assets-6.61%
Revenue/Share (TTM)$16.44
Book Value$2.19
Price-to-Book0.70
Price-to-Sales (TTM)0.09
EV/Revenue0.38
EV/EBITDA2.30
Quarterly Earnings Growth (YoY)7.50%
Quarterly Revenue Growth (YoY)45.60%
Shares Outstanding$84.78M
Float$52.93M
% Insiders21.69%
% Institutions21.24%

Historical Volatility

HV 10-Day
116.01%
HV 20-Day
108.95%
HV 30-Day
97.74%
HV 60-Day
85.18%
HV Rank
65.1%

Volatility is currently expanding

Latest News

So-Young: Revenue Acceleration Is Overshadowed By Widening Losses (Rating Downgrade)

I lower my rating for So-Young International from 'Buy' to 'Hold' after analyzing its mixed 1Q2026 performance. 1Q2026 revenues surged 46% YoY, as the pivot towards offline aesthetic clinics paid off. But SY's net losses widened year-on-year in the first quarter due to lower contributions from high-margin online operations and costs relating to footprint expansion.

Seeking Alpha5/26/2026Neutral
So-Young International Q1 Earnings Call Highlights

So-Young International NASDAQ: SY reported sharply higher first-quarter 2026 revenue, driven by rapid growth in its branded aesthetic center business, while management said the company is continuing to expand its clinic footprint and invest in standardized medical delivery.

MarketBeat5/22/2026Positive
So-Young Reports Unaudited First Quarter 2026 Financial Results

BEIJING, May 22, 2026 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced its unaudited financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Highlights Total revenues were RMB432.8 million (US$62.7 million[1]), compared with RMB297.3 million in the corresponding period of 2025.

PRNewsWire5/22/2026Neutral
So-Young to Report First Quarter 2026 Financial Results on May 22, 2026

BEIJING, May 14, 2026 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced that it will report its financial results for the first quarter ended March 31, 2026, before U.S. markets open on May 22, 2026. So-Young's management will hold an earnings conference call on Friday, May 22, 2026, at 7:30 AM U.S. Eastern Time (7:30 PM on the same day, Beijing/Hong Kong Time).

PRNewsWire5/14/2026Neutral
So-Young International Inc. Files Its Annual Report on Form 20-F

BEIJING, April 23, 2026 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the Securities and Exchange Commission on April 23, 2026. The annual report is available on the Company's investor relations website at https://ir.soyoung.com/.

PRNewsWire4/23/2026Neutral

More HEALTHCARE Stocks

Data last updated: 7/9/2026